Stockscreener 앱 받기
8.24
0.00%
0.00
Harvard Bioscience Inc 주식(HBIO)의 최신 뉴스
Harvard Bioscience creates scientific advisory board - Investing.com
Harvard Bioscience forms scientific advisory board with four members - StreetInsider
Harvard Bioscience Announces Creation Of Scientific Advisory Board - TradingView
Harvard Bioscience Announces Creation of Scientific Advisory Board - GlobeNewswire
Harvard Bioscience, Inc. Announces Creation of Scientific Advisory Board - www.marketscreener.com
Harvard Bioscience stock gained 1.92 percent on October 5, 2026 - AD HOC NEWS
Harvard Bioscience grows revenue 11.10 percent: what it means for Harvard Bioscience stock - AD HOC NEWS
North America Non-Viral Transfection Reagents Market Forecast to 2035 | Cell and Gene Therapy Demand Drives 8.5% CAGR and a USD 0.70 Billion Opportunity - GlobeNewswire Inc.
Harvard Bioscience stock holds at USD 7.92 after reverse split - AD HOC NEWS
Over 5% stake disclosed in Harvard Bioscience (HBIO) - Stock Titan
Harvard Bioscience stock trades steady as investors look to latest revenue trends - ad-hoc-news.de
Harvard (HBIO) Chart: Records a 0.13% Increase to $7.49; Price Context: the Price Remains Bounded by the Supplied Support and Resistance on the DayVolatility Surface - vinanet.vn
Harvard Bioscience Insider Confidence Rewarded, Stock Hits US$32m Market Cap - Sahm
Harvard Bioscience Insider Confidence Rewarded, Stock Hits US$32m Market Cap - simplywall.st
Harvard (HBIO) Results Review: EPS Exceeds Its Estimate in the Current Update; Session Move: The Stock Gains 1.58% at the CloseNet Profit Margin - vinanet.vn
Harvard Bioscience (HBIO) Q2 2026 Earnings Call Transcript - The Globe and Mail
Harvard Bioscience (HBIO) Q2 2026 Earnings Call Transcript - AOL.ca
Benchmark raises Harvard Bioscience stock price target on revenue beat By Investing.com - Investing.com South Africa
HBIO Maintained by Benchmark -- Price Target Raised to $7.50 - GuruFocus
Benchmark raises Harvard Bioscience stock price target on revenue beat - Investing.com
Benchmark raises Harvard Bioscience stock price target on revenue beat By Investing.com - Investing.com India
Benchmark raises Harvard Bioscience stock price target on revenue beat By Investing.com - Investing.com UK
Benchmark raises Harvard Bioscience stock price target on revenue beat - Investing.com
Harvard Bioscience, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:HBIO) 2026-08-12 - Seeking Alpha
Harvard Bioscience, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
HARVARD BIOSCIENCE INC 2026: Revenue $22.73M, EPS ($0.64) — 10-Q Summary - TradingView
Harvard Bioscience (NASDAQ: HBIO) grows Q2 sales but faces higher debt costs - Stock Titan
Harvard Bioscience Inc (HBIO) (Q2 2026) Earnings Call Highlights - GuruFocus
HBIO Looks 66.8% Undervalued on GF Value™ Despite Profitability Challenges - GuruFocus
Harvard Bioscience Inc (HBIO) (Q2 2026) Earnings Call Highlights: Revenue Surges 11% and ... - Yahoo Finance
Harvard Bioscience Releases Q2 2026 Financial Results - AlphaStreet
Earnings call transcript: Harvard Bioscience tops Q2 2026 forecasts, raises outlook - Investing.com Nigeria
HBio Q2 2026 slides: revenue up 11%, China growth drives guidance raise - Investing.com Nigeria
Harvard Bioscience beats Q2 estimates and raises 2026 revenue guidance - Yahoo Finance
Harvard Bioscience Raises Full-Year 2026 Revenue Guidance After Strong Second-Quarter Growth - Minichart
Earnings call transcript: Harvard Bioscience tops Q2 2026 forecasts, raises outlook - Investing.com
Why is Harvard Bioscience stock gaining today? By Investing.com - Investing.com Canada
Is Harvard Bioscience Inc (HBIO) Undervalued After Q2 Earnings B - GuruFocus
Harvard Bioscience beats estimates, raises 2026 guidance By Investing.com - Investing.com South Africa
Harvard Bioscience beats estimates, raises 2026 guidance By Investing.com - Investing.com Australia
Harvard Bioscience beats estimates, raises 2026 guidance By Investing.com - Investing.com Canada
Harvard Bioscience beats estimates, raises 2026 guidance - Investing.com
Harvard Bioscience beats estimates, raises 2026 guidance - Investing.com
Harvard Bioscience Announces Second Quarter 2026 Financial Results - The Manila Times
Harvard Bioscience: Q2 Earnings Snapshot - marketscreener.com
Harvard Bioscience: Q2 Earnings Snapshot - AOL.com
Harvard Bioscience: Q2 Earnings Snapshot - KTVB
Harvard Bioscience Q2 revenue rises on telemetry demand, lifts 2026 outlook - TradingView
Harvard Bioscience Q2 Revenue Rises 11 Percent to $22.7 Million - Quiver Quantitative
Harvard Bioscience Announces Second Quarter 2026 Financial Results - marketscreener.com
1.13%
0.57%
자본화:
|
볼륨(24시간):